IART - Integra LifeSciences Holdings Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue1,188,236992,075882,734796,717
Cost of Revenue407,098330,220309,121285,852
Gross Profit781,138661,855573,613510,865
Operating Expenses
Research Development63,45557,95549,93543,059
Selling General and Administrative520,419430,770376,996335,186
Non Recurring----
Others----
Total Operating Expenses1,011,342832,807746,005670,907
Operating Income or Loss176,894159,268136,729125,810
Income from Continuing Operations
Total Other Income/Expenses Net-165,509-68,862-76,058-80,244
Earnings Before Interest and Taxes176,894159,268136,729125,810
Interest Expense-35,019-25,803-23,534-21,967
Income Before Tax11,38590,40660,67145,566
Income Tax Expense-53,35815,84253,8209,271
Minority Interest----
Net Income From Continuing Ops64,74374,5646,85136,295
Non-recurring Events
Discontinued Operations---10,370-2,291
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income64,74374,564-3,51934,004
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares64,74374,564-3,51934,004